With only 4 weeks left until the Life Sciences Internal Audit Conference, February 8-9, 2012 in Philadelphia, PA, don’t miss out on your opportunity to attend the event!
Join key speakers, including:
Andy Weintraub, Director, Group Internal Audit at AstraZeneca
David Bolton, Internal Audit Manager at Biomet, Inc.
Tami McLaine, Director, Audit at Baxter International
Katie McCormick, Senior Manager, Corporate Analysis & Control at Boston Scientific Corporation
Jeffrey Antoon, Director, Corporate Internal Audit at Johnson & Johnson
Rosemary Scardaville, Audit Director at Merck
Robert Scala, Senior Director, Corporate Ethics and Compliance at Eisai, Inc.
And many, many more!
This practical, hands-on event will enable delegates to benchmark their Internal Audit strategies against their peers, and is a “must-attend” conference for industry leaders to discuss best practices on approaching internal audit compliance to increase effectiveness while decreasing cost and time.
Hear What Past Delegates Have to Say About the Internal Audit Conference Series:
”Great selection & breadth of speakers. Uniformly high quality presentations. Intimate nature of meeting provided excellent opportunities for networking” – Abbott Laboratories
“One of the best meetings I’ve attended. Excellent organization, topics and speakers. Overall extremely well done.” – Sanofi Aventis
For more information or to RECEIVE A DISCOUNTED RATE, contact Michele Westergaard at Michelew@marcusevansch.com or 312-540-3000 ext. 6625.
You need to be a member of Global Risk Community to add comments!
Comments